ER stress-mediated apoptosis induced by celastrol in cancer cells and important role of glycogen synthase kinase-3β in the signal network

HeLa cells treated with celastrol, a natural compound with inhibitive effect on proteasome, exhibited increase in apoptotic rate and characteristics of apoptosis. To clarify the signal network activated by celastrol to induce apoptosis, both the direct target proteins and undirect target proteins of celastrol were searched in the present study. Proteasome catalytic subunit β1 was predicted by computational analysis to be a possible direct target of celastrol and confirmed by checking direct effect of celastrol on the activity of recombinant human proteasome subunit β1 in vitro. Undirect target-related proteins of celastrol were searched using proteomic studies including two-dimensional electrophoresis (2-DE) analysis and iTRAQ-based LC-MS analysis. Possible target-related proteins of celastrol such as endoplasmic reticulum protein 29 (ERP29) and mitochondrial import receptor Tom22 (TOM22) were found by 2-DE analysis of total cellular protein expression profiles. Further study showed that celastrol induced ER stress and ER stress inhibitor could ameliorate cell death induced by celastrol. Celastrol induced translocation of Bax into the mitochondria, which might be related to the upregulation of BH-3-only proteins such as BIM and the increase in the expression level of TOM22. To further search possible target-related proteins of celastrol in ER and ER-related fractions, iTRAQ-based LC-MS method was use to analyze protein expression profiles of ER/microsomal vesicles-riched fraction of cells with or without celastrol treatment. Based on possible target-related proteins found in both 2-DE analysis and iTRAQ-based LC-MS analysis, protein–protein interaction (PPI) network was established using bioinformatic analysis. The important role of glycogen synthase kinase-3β (GSK3β) in the signal cascades of celastrol was suggested. Pretreatment of LiCL, an inhibitor of GSK3β, could significantly ameliorate apoptosis induced by celastrol. On the basis of the results of the present study, possible signal network of celastrol activated by celastrol leading to apoptosis was predicted.

[1]  J. Luk,et al.  Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo , 2012, Cancer Prevention Research.

[2]  Jingguo Li,et al.  Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model , 2012, International journal of nanomedicine.

[3]  R. Jope,et al.  The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.

[4]  Tao Zhang,et al.  A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells , 2008, Molecular Cancer Therapeutics.

[5]  R. Prather,et al.  Ubiquitin C-Terminal Hydrolase-Activity Is Involved in Sperm Acrosomal Function and Anti-Polyspermy Defense During Porcine Fertilization1 , 2007, Biology of reproduction.

[6]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[7]  B. McManus,et al.  Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. , 2003, The American journal of pathology.

[8]  S. Howng,et al.  GSK3beta regulates Bcl2L12 and Bcl2L12A anti‐apoptosis signaling in glioblastoma and is inhibited by LiCl , 2012, Cell cycle.

[9]  M. Horne,et al.  Bim Links ER Stress and Apoptosis in Cells Expressing Mutant SOD1 Associated with Amyotrophic Lateral Sclerosis , 2012, PloS one.

[10]  A. Zmijewska,et al.  Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells. , 2011, Experimental cell research.

[11]  Induction of heat shock proteins in cerebral cortical cultures by celastrol , 2013, Cell Stress and Chaperones.

[12]  T. Laessig,et al.  Glycogen Synthase Kinase-3β Phosphorylates Bax and Promotes Its Mitochondrial Localization during Neuronal Apoptosis , 2004, The Journal of Neuroscience.

[13]  T. Miura,et al.  The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis. , 2012, Cardiovascular research.

[14]  B. Zhivotovsky,et al.  Mitochondrial targeting of tBid/Bax: a role for the TOM complex? , 2009, Cell Death and Differentiation.

[15]  C. Li,et al.  Bcl-2 proteins regulate ER membrane permeability to luminal proteins during ER stress-induced apoptosis , 2011, Cell Death and Differentiation.

[16]  R. Jope,et al.  Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation , 2003, Journal of neurochemistry.

[17]  J. Mogridge,et al.  Inhibition of Anthrax Lethal Toxin-Induced Cytolysis of RAW264.7 Cells by Celastrol , 2008, PloS one.

[18]  Di Chen,et al.  Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. , 2006, Cancer research.

[19]  A. Salminen,et al.  Celastrol: Molecular targets of Thunder God Vine. , 2010, Biochemical and biophysical research communications.

[20]  Z. Zuo,et al.  Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity. , 2011, European journal of pharmacology.

[21]  B. Zhivotovsky,et al.  The Mitochondrial TOM Complex Is Required for tBid/Bax-induced Cytochrome c Release* , 2007, Journal of Biological Chemistry.

[22]  X. Ji,et al.  Celastrol causes apoptosis and cell cycle arrest in rat glioma cells , 2010, Neurological research.

[23]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[24]  D. Guo,et al.  Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes , 2008, Cancer science.

[25]  Tomomi Gotoh,et al.  ER Stress Triggers Apoptosis by Activating BH3-Only Protein Bim , 2007, Cell.

[26]  Y. Hsu,et al.  Conformation of the Bax C‐terminus regulates subcellular location and cell death , 1999, The EMBO journal.

[27]  R. Jope,et al.  Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation* , 2002, The Journal of Biological Chemistry.

[28]  Koichi Abe,et al.  Peptide ligand screening of α-synuclein aggregation modulators by in silico panning , 2007, BMC Bioinformatics.

[29]  Xiaohua Li,et al.  In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors , 2006, Neurobiology of Aging.

[30]  H. Schwalbe,et al.  Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. , 2009, Angewandte Chemie.

[31]  G. Werstuck,et al.  Endoplasmic Reticulum Stress and Glycogen Synthase Kinase-3&bgr; Activation in Apolipoprotein E–Deficient Mouse Models of Accelerated Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Y. Hsu,et al.  Bax translocates from cytosol to mitochondria in cardiac cells during apoptosis: development of a GFP-Bax-stable H9c2 cell line for apoptosis analysis. , 2005, American journal of physiology. Heart and circulatory physiology.

[33]  Ming Chen,et al.  Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells , 2009, Molecular Cancer Research.

[34]  K. Ross,et al.  TOM-independent complex formation of Bax and Bak in mammalian mitochondria during TNFα-induced apoptosis , 2009, Cell Death and Differentiation.

[35]  K. Park,et al.  Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  G. Sethi,et al.  Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways , 2011, Apoptosis.

[37]  Lin Qiu,et al.  Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. , 2010, Cancer letters.

[38]  T. Tsuruo,et al.  Modulation of Akt kinase activity by binding to Hsp90. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Byung-Hoon Lee,et al.  Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β. , 2012, Biochemical and biophysical research communications.

[40]  P. Zhao,et al.  Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  K. Roth,et al.  CHOP Potentially Co-Operates with FOXO3a in Neuronal Cells to Regulate PUMA and BIM Expression in Response to ER Stress , 2012, PloS one.

[42]  R. Jope,et al.  Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium , 2001, Brain Research.

[43]  Guang-Biao Zhou,et al.  The Main Anticancer Bullets of the Chinese Medicinal Herb, Thunder God Vine , 2011, Molecules.

[44]  P. Bornstein,et al.  TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax , 2007, Cell Death and Differentiation.

[45]  Daohai Zhang,et al.  Endoplasmic reticulum protein 29 (ERp29): An emerging role in cancer. , 2011, The international journal of biochemistry & cell biology.

[46]  J. Woodgett,et al.  Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.

[47]  K. Tozawa,et al.  Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway. , 2011, International journal of oncology.

[48]  L. Hendershot,et al.  Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. , 2002, Journal of molecular biology.

[49]  De-An Guo,et al.  Proteomics Characterization of the Cytotoxicity Mechanism of Ganoderic Acid D and Computer-automated Estimation of the Possible Drug Target Network*S , 2008, Molecular & Cellular Proteomics.

[50]  W. Neupert,et al.  Lateral release of proteins from the TOM complex into the outer membrane of mitochondria , 2011, The EMBO journal.

[51]  Jia Luo,et al.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. , 2009, Cancer letters.

[52]  Yee‐Shin Lin,et al.  Glycogen Synthase Kinase-3β Mediates Endoplasmic Reticulum Stress-Induced Lysosomal Apoptosis in Leukemia , 2009, Journal of Pharmacology and Experimental Therapeutics.

[53]  K. Kawakami,et al.  An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta. , 2009, Anti-cancer agents in medicinal chemistry.

[54]  A. Zmijewska,et al.  HSP105 interacts with GRP78 and GSK3 and promotes ER stress-induced caspase-3 activation. , 2008, Cellular signalling.

[55]  F. Urano,et al.  Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. , 2000, Science.

[56]  Wei‐ping Chen,et al.  Celastrol, an inhibitor of heat shock protein 90β potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes. , 2013, European journal of pharmacology.

[57]  M. Priault,et al.  The cytosolic domain of human Tom22 modulates human Bax mitochondrial translocation and conformation in yeast , 2012, FEBS letters.

[58]  Wan-ying Wu,et al.  Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90 , 2012, Journal of cellular physiology.

[59]  M. Salto‐Tellez,et al.  Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal–epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells , 2009, Laboratory Investigation.